Apricus Biosciences Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Apricus Biosciences

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

From: mokelumne river	3/9/2016 8:27:08 PM
	Read Replies (2) of 2026

I listened to the short conference call today. Pascoe did confirm that Fis results were going to be announced this month. We (and maybe the company) are pretty much in the dark about what happens next with Fis. Obviously a Phase III is next, but how good do the results have to be to launch in that direction and how much that will cost and where will the money come from remain the open questions. At least we will know the results very soon. We could use a break with good results. It certainly seems that "the street" does not expect good results, or could care less about Fis since marketing is years away even with good results. I was wondering how RayVa was doing, but it wasn't mentioned today. Dr. Barbara confirmed what Eman has reported several times, that no clinical studies are anticipated to file an NDA with the FDA for Vitaros. Thank goodness. I would think FDA approval should be a big deal for us...maybe in terms of getting a partner. But with Vitaros not exactly flying off the shelves across the pond, we might be disappointed in lack of interest by a big pharma. I should note that we have not received any milestones for Vitaros sales. We get much better info when Eman is able to get one on one with Pascoe.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next